Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan (Q35229601)

7 August 2017

title

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan (English)

1 reference

7 August 2017

1 reference

Florent L Besson

2

0 references

Renaud La Joie

object named as

Renaud La Joie

4

0 references

author name string

Marine Fouquet

1

1 reference

7 August 2017

Julie Gonneaud

3

1 reference

7 August 2017

Gaël Chételat

5

1 reference

7 August 2017

publication date

22 August 2014

1 reference

7 August 2017

published in

Neuropsychology Review

1 reference

7 August 2017

volume

24

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

290-299

1 reference

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Patterns of brain activation in people at risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Functional brain connectivity using fMRI in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Family history of Alzheimer's disease and hippocampal structure in healthy people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Family history and APOE-4 genetic risk in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Age effects on atrophy rates of entorhinal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Differential effects of the APOE genotype on brain function across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Accelerating cortical thinning: unique to dementia or universal in aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Episodic memory on the path to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

White matter integrity and vulnerability to Alzheimer's disease: Preliminary findings and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Alzheimer mechanisms and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

APOE modifies the association between Aβ load and cognition in cognitively normal older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

The role of apolipoprotein E in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Common variants in psychiatric risk genes predict brain structure at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Aβ amyloid, cognition, and APOE genotype in healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Association of hypometabolism and amyloid levels in aging, normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

In vivo assessment of amyloid-β deposition in nondemented very elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Differential effects of the ApoE4 genotype on brain structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Indicators of amyloid burden in a population-based study of cognitively normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Glucose metabolism and gray-matter concentration in apolipoprotein E ε4 positive normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Design considerations for characterizing psychiatric trajectories across the lifespan: application to effects of APOE-ε4 on cerebral cortical thickness in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ϵ4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

The effects of APOE-ε4 on the BOLD response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Increased Hippocampal Default Mode Synchronization during Rest in Middle-Aged and Elderly APOE ε4 Carriers: Relationships with Memory Performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11065-014-9263-8

Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates

21 January 2018

1 reference

12 December 2020

Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.

1 reference

12 December 2020

Hippocampal sulcal cavities on MRI: relationship to age and apolipoprotein E genotype

1 reference

12 December 2020

Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study

1 reference

12 December 2020

The Apolipoprotein E Antagonistic Pleiotropy Hypothesis: Review and Recommendations

1 reference

12 December 2020

APOE genotype and entorhinal cortex volume in non-demented community-dwelling adults in midlife and early old age.

1 reference

12 December 2020

Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly

1 reference

12 December 2020

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease

1 reference

12 December 2020

What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus

1 reference

12 December 2020

Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.

1 reference

12 December 2020

Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates

1 reference

12 December 2020

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers

1 reference

12 December 2020

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele

1 reference

12 December 2020

APOE ε2 allele is associated with larger regional cortical thicknesses and volumes.

1 reference

12 December 2020

Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study

1 reference

12 December 2020

Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging".

1 reference

12 December 2020

No differences in hippocampal volume between carriers and non-carriers of the ApoE ε4 and ε2 alleles in young healthy adolescents

1 reference

12 December 2020

Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study

1 reference

12 December 2020

Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.

1 reference

12 December 2020

Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers

1 reference

12 December 2020

10.1007/S11065-014-9263-8

Identifiers

DOI

1 reference

7 August 2017

1 reference